Martin, Niall M. B.
Mission Therapeutics (United Kingdom) · Artios Pharma Limited (United Kingdom)
3 papers on CoChatORCID 0009-0002-2068-1600
Most cited papers
- Verified
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature
PARP inhibition in cancer therapyDNA Repair Mechanisms
Cited by 6,683
- Verified
Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM
Hickson, I., Zhao, Y., Richardson, C. J., Green, S. J., Martin, N. M. B., Orr, A. I., Reaper, P. M., Jackson, S. P., Curtin, N. J., & Smith, G. C. M. (2004) · Cancer Research
DNA Repair MechanismsEffects of Radiation Exposure
Cited by 1,220
- Verified
Deubiquitylating enzymes and drug discovery: emerging opportunities
Harrigan, J. A., Jacq, X., Martin, N. M., & Jackson, S. P. (2018) · Nature Reviews Drug Discovery
Ubiquitin and proteasome pathwaysProtein Degradation and Inhibitors
Cited by 940
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free